ARC-AAT Injection
ARCAAT2001
Phase 2 small_molecule terminated
Quick answer
ARC-AAT Injection for Alpha-1 Antitrypsin Deficiency is a Phase 2 program (small_molecule) at Arrowhead Pharmaceuticals Ireland Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Arrowhead Pharmaceuticals Ireland Limited
- Indication
- Alpha-1 Antitrypsin Deficiency
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated